3 Reasons Intrexon Stock Could Fall

Published: Nov 23, 2016

Intrexon's (NYSE:XON) sheer number of shots on goal shows tremendous promise for the engineered biology conglomerate. Products in development or nearing commercial launch include everything from genetically engineered mosquitoes for public health to pet cloning services, and from CAR-T immunotherapy to controlled flowering of agricultural crops. Of course, as with any stock, there are always risks and pitfalls. So while I recently went over three reasons the company's shares could rise, let's now consider three reasons Intrexon's stock could fall.

Back to news